These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11871210)

  • 1. [Is heart rate reduction beneficial to patients with heart insufficiency? Focus on beta-blockade].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 2002 Jan; 164(5):615-9. PubMed ID: 11871210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk reduction of acute heart failure with initial administration of beta-blockers].
    Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological treatment of heart failure].
    Kohno M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():660-6. PubMed ID: 12735047
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficient drugs, reconstructive surgery and "heart assist" are alternatives to transplantation. It's possible to treat severe heart failure].
    Swedberg K
    Lakartidningen; 2000 May; 97(20):2434-5. PubMed ID: 10909219
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of heart failure treatment.
    Guyatt GH; Devereaux PJ
    Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of recent clinical trials in heart failure and myocardial infarction.
    Richardson M; Cockburn N; Cleland JG
    Eur J Heart Fail; 1999 Mar; 1(1):109-15. PubMed ID: 10937988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 13. The enigma of quality of life in patients with heart failure.
    Dobre D; de Jongste MJ; Haaijer-Ruskamp FM; Sanderman R; van Veldhuisen DJ; Ranchor AV
    Int J Cardiol; 2008 Apr; 125(3):407-9. PubMed ID: 17400313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
    Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of heart failure drug trials: COMET, CHARM, EPHESUS.
    Hiestand B; Abraham WT
    Rev Cardiovasc Med; 2005; 6 Suppl 2():S4-11. PubMed ID: 15891699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exercise test in the evaluation of the efficacy of drug therapy].
    Febo O; Cobelli F
    Ital Heart J Suppl; 2000 Mar; 1(3):393-9. PubMed ID: 10815269
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure--and an interaction with beta blockade.
    Coats AJ
    Int J Cardiol; 2001 Jan; 77(1):1-4. PubMed ID: 11150619
    [No Abstract]   [Full Text] [Related]  

  • 20. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.